<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18701259</PMID><DateCompleted><Year>2008</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0924-8579</ISSN><JournalIssue CitedMedium="Print"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2008</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of antimicrobial agents</Title><ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation></Journal><ArticleTitle>Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71.</ArticleTitle><Pagination><StartPage>355</StartPage><EndPage>359</EndPage><MedlinePgn>355-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2008.04.018</ELocationID><Abstract><AbstractText>In this study, aloe-emodin was identified as a potential interferon (IFN)-inducer by screening compounds from Chinese herbal medicine. Aloe-emodin showed low cytotoxicity to human HL-CZ promonocyte cells and TE-671 medulloblastoma cells and significantly activated interferon-stimulated response element (ISRE) and gamma-activated sequence (GAS)-driven cis-reporting systems. Moreover, aloe-emodin upregulated expression of IFN-stimulated genes such as dsRNA-activated protein kinase and 2',5'-oligoisoadenylate synthase. Aloe-emodin resulted in significant activation of nitric oxide production. The antiviral activity of aloe-emodin against Japanese encephalitis virus (JEV) and enterovirus 71 (EV71) was evaluated using dose- and time-dependent plaque reduction assays in HL-CZ cells and TE-671 cells. The 50% inhibitory concentration (IC(50)) of aloe-emodin ranged from 0.50microg/mL to 1.51microg/mL for JEV and from 0.14microg/mL to 0.52microg/mL for EV71. Aloe-emodin showed clearly potent virus inhibitory abilities and achieved high therapeutic indices, in particular for HL-CZ cells. Therefore, the study demonstrated dose- and time-dependent actions of aloe-emodin on the inhibition of JEV and EV71 replication via IFN signalling responses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Cheng-Wen</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan. cwlin@mail.cmu.edu.tw</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chia-Fang</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Hsiao</LastName><ForeName>Nai-Wan</ForeName><Initials>NW</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ching-Yao</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shih-Wein</ForeName><Initials>SW</Initials></Author><Author ValidYN="Y"><LastName>Wan</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ying-Ju</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wei-Yong</ForeName><Initials>WY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Antimicrob Agents</MedlineTA><NlmUniqueID>9111860</NlmUniqueID><ISSNLinking>0924-8579</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000880">Anthraquinones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>C8IYT9CR7C</RegistryNumber><NameOfSubstance UI="C518327">aloe emodin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000504" MajorTopicYN="N">Aloe</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000880" MajorTopicYN="N">Anthraquinones</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008516" MajorTopicYN="Y">Medicine, Chinese Traditional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2008</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>8</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>12</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>8</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2008</Year><Month>8</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18701259</ArticleId><ArticleId IdType="pmc">PMC7126984</ArticleId><ArticleId IdType="doi">10.1016/j.ijantimicag.2008.04.018</ArticleId><ArticleId IdType="pii">S0924-8579(08)00204-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sydiskis R.J., Owen D.G., Lohr J.L., Rosler K.H., Blomster R.N. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother. 1991;35:2463&#x2013;2466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC245413</ArticleId><ArticleId IdType="pubmed">1810179</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard D.L., Huffman J.H., Morris J.L., Wood S.G., Hughes B.G., Sidwell R.W. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res. 1992;17:63&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">1310583</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuangsuo D., Zhengguo Z., Yunru C. Inhibition of the replication of hepatitis B virus in vitro by emodin. Med Sci Monit. 2006;12:BR302&#x2013;BR306.</Citation><ArticleIdList><ArticleId IdType="pubmed">16940925</ArticleId></ArticleIdList></Reference><Reference><Citation>Semple S.J., Pyke S.M., Reynolds G.D., Flower R.L. In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus. Antiviral Res. 2001;49:169&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11428243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki O., Karaki T., Imanishi J. Protective effect of interferon on infections with hand, foot, and mouth disease virus in newborn mice. J Infect Dis. 1986;153:498&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">3005425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis M., Amsden J.R. Successful treatment of West Nile virus infection after approximately 3 weeks into the disease course. Pharmacotherapy. 2007;27:455&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">17316156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.L., Huang Y.L., Ma S.H. Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol. 1997;71:5227&#x2013;5235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191758</ArticleId><ArticleId IdType="pubmed">9188590</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.P., Wang Y.F. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol. 2005;86:3263&#x2013;3269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke D.S., Monath T.P. Flaviviridae. In: Knipe D.M., Howley P.M., editors. Fields virology. 4th ed. Lippincott-Williams and Wilkins; New York: 2001. pp. 1043&#x2013;1125.</Citation></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.W., Huang H.D., Shiu S.Y. Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease. Virus Res. 2007;127:88&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">17467838</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyaerts E., Vijgen L., Chen L., Maes P., Hedenstierna G., Van Ranst M. Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. Int J Infect Dis. 2004;8:223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7128975</ArticleId><ArticleId IdType="pubmed">15234326</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Yang L., Oppenheim J.J., Howard M.Z. Cellular pharmacological study of shikonin derivatives. Phytother Res. 2002;16:199&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">12164262</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang E.E., Miao Z.F., Lee W.J. Arecoline inhibits the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1A1 activation in human hepatoma cells. J Hazard Mater. 2007;146:356&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">17234337</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>